Jeanny B. Aragon-Ching, M.D.
Dr. Aragon-Ching is a specialty Oncology care physician board certified in medical oncology, hematology and internal medicine. She joins Inova Medical Group with over 15 years of clinical experience. She has a special interest in management of genitourinary (GU) cancers (prostate, bladder, kidney and testicular cancers).
Otis W. Brawley, M.D.
Otis W. Brawley, M.D., is the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He is an authority on cancer screening and prevention and leads a broad interdisciplinary research effort focused on cancer health disparities at the Johns Hopkins School of Medicine, the Bloomberg School of Public Health and the Sidney Kimmel Comprehensive Cancer Center.
David Brown brings over 40 years of management experience to his consulting, having held senior management positions in medical research, higher education, foundation management, investment management, and technology.
As founder and President of Brown Philanthropy Advisors, Pam has 30 years of experience in providing philanthropic advice, strategic planning, and management consulting to nonprofit and for-profit executives, board members, and donors seeking to maximize impact and effectiveness.
Robert L. Grossman
Robert L. Grossman is the Frederick H. Rawson Distinguished Service Professor in Medicine and Computer Science and the Jim and Karen Frank Director of the Center for Translational Data Science at the University of Chicago.
Adam R. Metwalli, M.D.
Adam R. Metwalli, MD, is a Professor in the Howard University College of Medicine and Chief of Urology in the Department of Surgery at Howard University Hospital. Dr. Metwalli is a urologic oncologist trained in robotic surgery and specializing in cancers of the kidney, prostate, bladder, penis and testis.
Donald L. Trump M.D.
Dr. Donald L. Trump, also known as Skip, FACP & M.D. serves as Chief Executive Officer and Executive Director of Inova Schar Cancer Institute at Inova Health Systems, Inc..